Statins and Myasthenia Gravis: Clinical Implications and Pathogenesis
Xiao Tian, Peixiang Zhang · 2026
Read Statins and Myasthenia Gravis: Clinical Implications and Pathogenesis by Xiao Tian, Peixiang Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13607078.txt.
Description
Tian and Zhang review in 2026 the links between statin drugs and myasthenia gravis, a disease of weak muscle signaling. Statins are central to preventing artery disease and are usually well borne. Case reports and drug safety data tie them to new or worsened cases of the muscle disease, though.
Recent population data strengthen that temporal link in their account. The review splits statin linked cases from other statin muscle syndromes, which need unlike care. Proposed paths span sugar chain changes, immune shifts, receptor clustering harm, and cell energy strain. A combined framework is offered to guide future study and risk based care.
Catalog record
| CREATOR | Xiao Tian, Peixiang Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |